Skip to main content
    M

    Moderna Inc (MRNA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $215.27
    -8.10 (-3.63%)

    Market Cap: $90.38B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Moderna Inc (MRNA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Moderna are Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX) and argenx NV ADR (ARGX). By market cap, Moderna ranks 3rd of the 13 companies on this page; Vertex Pharmaceuticals (VRTX) is the largest at $136.56B. The median P/E of the 7 companies with a P/E is 30.0x.

    Peer Comparison

    MRNA's ROIC of -28.9% is below the peer median of 6.2%, and its revenue growth of 29.2% is above the median of 14.7%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Moderna (MRNA)$90.38BN/A34.2x-110.5%-28.9%29.2%0.00%
    Regeneron Pharmaceuticals Inc (REGN)$98.84B18.4x5.7x28.5%13.7%36.3%0.39%
    Vertex Pharmaceuticals Inc (VRTX)$136.56B30.0x10.5x30.7%14.2%11.8%0.00%
    argenx NV ADR (ARGX)$60.37B33.5x6.1x31.7%N/A52.1%0.00%
    BeOne Medicines AG (ONC)$47.58B50.0x18.7x13.9%7.5%33.8%0.00%
    Revolution Medicines Inc (RVMD)$37.27BN/A181.6x0.0%-52.1%-95.2%0.00%
    Genmab AS (GMAB)$31.67B35.8x19.2x17.0%4.8%16.1%0.00%
    Royalty Pharma Plc (RPRX)$39.85B12.9x11.7x25.7%7.6%13.3%1.37%
    Insmed Inc (INSM)$26.58BN/A17.7x-39.9%-44.2%268.4%0.00%
    Roivant Sciences Ltd (ROIV)$28.64BN/A679.3x0.0%N/A2136.0%0.00%
    Novavax Inc (NVAX)$1.41BN/A3.2x-18.6%-66.6%-3.0%0.00%
    MacroGenics Inc (MGNX)$140.60MN/A1.2x-36.6%-108.7%-64.8%0.00%
    CorMedix Inc (CRMD)$370.64M6.3x0.9x15.5%13.9%-47.7%0.00%
    Peer median$34.47B30.0x11.1x14.7%6.2%14.7%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Moderna, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Regeneron Pharmaceuticals Inc (REGN)
    Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.
    REGN competitors
    Vertex Pharmaceuticals Inc (VRTX)
    Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
    VRTX competitors
    argenx NV ADR (ARGX)
    argenx SE, a clinical-phase biotechnology company, focuses on the development of antibody-based therapies for the treatment of autoimmune diseases...
    ARGX competitors
    BeOne Medicines AG (ONC)
    BeiGene, Ltd., an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe...
    ONC competitors
    Revolution Medicines Inc (RVMD)
    Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted...
    RVMD competitors
    Genmab AS (GMAB)
    Genmab A / S develops antibody therapies for the treatment of cancer and other diseases mainly in Denmark. The company is headquartered in Copenhagen, Denmark.
    GMAB competitors
    Royalty Pharma Plc (RPRX)
    Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States.
    RPRX competitors
    Insmed Inc (INSM)
    Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases.
    INSM competitors
    Roivant Sciences Ltd (ROIV)
    Roivant Sciences Ltd (ROIV) is a transformative biopharmaceutical company focused on advancing drug development and commercialization through a distinctive...
    ROIV competitors
    Novavax Inc (NVAX)
    Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases...
    NVAX competitors
    MacroGenics Inc (MGNX)
    MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapies to treat cancer in the United States.
    MGNX competitors
    CorMedix Inc (CRMD)
    CorMedix Inc., a biopharmaceutical company, focuses on developing and marketing therapeutic products for the prevention and treatment of infectious...
    CRMD competitors

    Frequently Asked Questions About MRNA

    Who are Moderna's main competitors?

    The companies most similar to Moderna include Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), argenx NV ADR (ARGX), BeOne Medicines AG (ONC) and Revolution Medicines (RVMD), listed from the closest match.

    Who is Moderna's biggest competitor?

    Vertex Pharmaceuticals (VRTX) is the largest of the similar companies at $136.56B; Regeneron Pharmaceuticals (REGN) is the closest match by business profile, size, sector and industry.

    How does MRNA stock compare with its competitors?

    MRNA's P/S is 34.2x against a peer median of 11.1x; its net margin is -110.5% against a peer median of 14.7%.

    Which of Moderna's competitors pays a higher dividend?

    Moderna pays no dividend. Royalty Pharma Plc (RPRX) and Regeneron Pharmaceuticals (REGN) have higher forward dividend yields; Royalty Pharma Plc (RPRX) has the highest at 1.37%.

    Is Moderna bigger than its competitors?

    No. Moderna is 3rd by market cap among the 13 companies on this page; the largest is Vertex Pharmaceuticals (VRTX) at $136.56B.